Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia
Dementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/12/914 |
id |
doaj-38a43c2bc5fa40249176ea94fdea45b2 |
---|---|
record_format |
Article |
spelling |
doaj-38a43c2bc5fa40249176ea94fdea45b22020-11-28T00:02:18ZengMDPI AGBrain Sciences2076-34252020-11-011091491410.3390/brainsci10120914Amino Acid Levels as Potential Biomarker of Elderly Patients with DementiaEdyta Socha0Piotr Kośliński1Marcin Koba2Katarzyna Mądra-Gackowska3Kornelia Kędziora-Kornatowska4Marcin Gackowski5Emilia Daghir-Wojtkowiak6Department of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Geriatrics, Faculty of Health Sciences, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Geriatrics, Faculty of Health Sciences, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum of Nicolaus Copernicus University, 85-067 Bydgoszcz, PolandDepartment of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, 80-210 Gdańsk, PolandDementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is increasing dramatically with aging populations in most countries. Alzheimer’s disease is the predominant and leading cause of dementia. The aim of this study was to evaluate the modifications of amino acids that characterize the initial stages of dementia to help our understanding of the complex and multifactorial pathogenesis of neurodegenerative disorders. A total of 123 participants were divided into two groups: healthy elderly subjects and patients with mild or moderate dementia. The results of this study indicate that the serum levels of three amino acids were changed significantly in patients with dementia, in relation to the subjects without dementia. In particular, we observed differences in concentrations for serine, arginine and isoleucine (all of them were significantly increased in patients with dementia, compared with the control group). Our results suggest that the metabolisms of some amino acids seem be changed in patients with dementia. We conclude that amino acid profiling might be helpful for the better understanding of biochemical and metabolic changes related to the pathogenesis and progression of dementia. However, considering the multifactorial, heterogenous and complex nature of this disease, validation with a greater study sample in further research is required.https://www.mdpi.com/2076-3425/10/12/914neurodegenerative diseasesmild dementiamoderate dementiaamino acidsarginineserine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Edyta Socha Piotr Kośliński Marcin Koba Katarzyna Mądra-Gackowska Kornelia Kędziora-Kornatowska Marcin Gackowski Emilia Daghir-Wojtkowiak |
spellingShingle |
Edyta Socha Piotr Kośliński Marcin Koba Katarzyna Mądra-Gackowska Kornelia Kędziora-Kornatowska Marcin Gackowski Emilia Daghir-Wojtkowiak Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia Brain Sciences neurodegenerative diseases mild dementia moderate dementia amino acids arginine serine |
author_facet |
Edyta Socha Piotr Kośliński Marcin Koba Katarzyna Mądra-Gackowska Kornelia Kędziora-Kornatowska Marcin Gackowski Emilia Daghir-Wojtkowiak |
author_sort |
Edyta Socha |
title |
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia |
title_short |
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia |
title_full |
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia |
title_fullStr |
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia |
title_full_unstemmed |
Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia |
title_sort |
amino acid levels as potential biomarker of elderly patients with dementia |
publisher |
MDPI AG |
series |
Brain Sciences |
issn |
2076-3425 |
publishDate |
2020-11-01 |
description |
Dementia is a clinical syndrome characterized by cognitive impairment, in which there is disturbance of multiple higher cortical functions. The primary risk factor of dementia is old age, and due to significant changes in the worldwide demographic structure, the prevalence of cognitive impairment is increasing dramatically with aging populations in most countries. Alzheimer’s disease is the predominant and leading cause of dementia. The aim of this study was to evaluate the modifications of amino acids that characterize the initial stages of dementia to help our understanding of the complex and multifactorial pathogenesis of neurodegenerative disorders. A total of 123 participants were divided into two groups: healthy elderly subjects and patients with mild or moderate dementia. The results of this study indicate that the serum levels of three amino acids were changed significantly in patients with dementia, in relation to the subjects without dementia. In particular, we observed differences in concentrations for serine, arginine and isoleucine (all of them were significantly increased in patients with dementia, compared with the control group). Our results suggest that the metabolisms of some amino acids seem be changed in patients with dementia. We conclude that amino acid profiling might be helpful for the better understanding of biochemical and metabolic changes related to the pathogenesis and progression of dementia. However, considering the multifactorial, heterogenous and complex nature of this disease, validation with a greater study sample in further research is required. |
topic |
neurodegenerative diseases mild dementia moderate dementia amino acids arginine serine |
url |
https://www.mdpi.com/2076-3425/10/12/914 |
work_keys_str_mv |
AT edytasocha aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT piotrkoslinski aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT marcinkoba aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT katarzynamadragackowska aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT korneliakedziorakornatowska aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT marcingackowski aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia AT emiliadaghirwojtkowiak aminoacidlevelsaspotentialbiomarkerofelderlypatientswithdementia |
_version_ |
1724413234239242240 |